4//SEC Filing
KOCH KEVIN 4
Accession 0001562180-25-005795
CIK 0001710072other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:42 PM ET
Size
17.3 KB
Accession
0001562180-25-005795
Insider Transaction Report
Form 4
KOCH KEVIN
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2025-08-12+87,500→ 87,500 totalExercise: $0.00Exp: 2035-08-12→ Common Stock (87,500 underlying) - Exercise/Conversion
Common Stock
2025-08-12+17,968→ 38,587 total - Sale
Common Stock
2025-08-12$13.39/sh−7,972$106,764→ 30,615 total - Exercise/Conversion
Restricted Stock Units
2025-08-12−17,968→ 53,907 totalExercise: $0.00Exp: 2034-08-12→ Common Stock (17,968 underlying) - Award
Stock Option (Right to Buy)
2025-08-12+525,000→ 525,000 totalExercise: $13.39Exp: 2035-08-12→ Common Stock (525,000 underlying)
Holdings
- 259,554(indirect: By LLC)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person
- [F2]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025.
- [F4]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026.
- [F5]1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001185829
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 7:42 PM ET
- Size
- 17.3 KB